L’Oréal Groupe and Korea-based RNA interference (RNAi) specialist OliX Pharmaceuticals have announced an exclusive scientific ...

Samsung Bioepis said Monday it has entered into a partnership agreement with Japan's NIPRO Corporation to commercialize ...

Severance Health Check-Up, the health promotion center affiliated with Severance Hospital, has been named Korea’s top brand ...

Korea’s Ministry of Food and Drug Safety has approved a phase 3 trial of Amgen’s siRNA therapy olpasiran, clearing the way ...

CHICAGO, Ill. -- By Hong Sook, Korea Biomedical Review correspondent -- "We are focused on generating synergistic clinical ...

A deep learning model developed by researchers at Yonsei University has shown near-perfect performance in identifying the ...

Four out of five trainee doctors have left their training hospitals, but the remaining senior doctors are now considering how ...

In preclinical models of GBA1-linked Parkinson’s disease, a genetic subset accounting for up to 15 percent of cases of the ...

SK plasma has signed a joint development and licensing agreement with antibody-drug conjugate (ADC) specialist AIMEDBIO to co ...

The growth engine of Korea's medical device industry has stalled. As of 2024, production fell by 1.7 percent year-on-year.

CHICAGO, Ill. – By Hong Sook / Korea Biomedical Review correspondent -- Pin Therapeutics has set about to target rare cancers ...

HLB’s VEGFR inhibitor rivoceranib is drawing renewed attention following a trio of phase 2 data readouts presented at the ...